Cross Country Healthcare (CCRN) Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cross Country Healthcare in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CCRN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CCRN, but not buy additional shares or sell existing shares.
View CCRN analyst ratings or view top-rated stocks.

6 equities research analysts have issued 1 year target prices for Cross Country Healthcare's shares. Their CCRN share price forecasts range from $7.50 to $40.00. On average, they expect the company's stock price to reach $26.58 in the next year. This suggests that the stock has a possible downside of 4.6%.
View analysts price targets for CCRN or view top-rated stocks among Wall Street analysts.

Cross Country Healthcare's stock was trading at $26.57 at the start of the year. Since then, CCRN shares have increased by 4.9% and is now trading at $27.86.
View the best growth stocks for 2023 here.

Cross Country Healthcare saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 5,300,000 shares, a decline of 10.5% from the April 30th total of 5,920,000 shares. Based on an average trading volume of 631,500 shares, the short-interest ratio is currently 8.4 days. Currently, 15.6% of the company's stock are short sold.
View Cross Country Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our CCRN earnings forecast.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) issued its earnings results on Wednesday, May, 3rd. The business services provider reported $0.84 earnings per share for the quarter, beating analysts' consensus estimates of $0.76 by $0.08. The business services provider had revenue of $622.71 million for the quarter, compared to analyst estimates of $594.09 million. Cross Country Healthcare had a trailing twelve-month return on equity of 37.57% and a net margin of 5.90%. The business's revenue for the quarter was down 21.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.70 earnings per share.

ETFs with the largest weight of Cross Country Healthcare (NASDAQ:CCRN) stock in their portfolio include Cambria Value and Momentum ETF (VAMO), SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Roundhill Acquirers Deep Value ETF (DEEP), Janus Henderson Small Cap Growth Alpha ETF (JSML), Hartford Multifactor Small Cap ETF (ROSC), Invesco S&P SmallCap Health Care ETF (PSCH) and Invesco S&P SmallCap Value with Momentum ETF (XSVM).

Cross Country Healthcare issued an update on its second quarter 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $0.55-$0.65 for the period, compared to the consensus earnings per share estimate of $0.75. The company issued revenue guidance of $530.00 million-$540.00 million, compared to the consensus revenue estimate of $553.92 million.

39 employees have rated Cross Country Healthcare Chief Executive Officer John Martins on Glassdoor.com. John Martins has an approval rating of 73% among the company's employees. 86.0% of employees surveyed would recommend working at Cross Country Healthcare to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cross Country Healthcare investors own include NVIDIA (NVDA), Energy Transfer (ET), OPKO Health (OPK), Enphase Energy (ENPH), Overstock.com (OSTK), QUALCOMM (QCOM), Vista Outdoor (VSTO), Twilio (TWLO), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Cross Country Healthcare trades on the NASDAQ under the ticker symbol "CCRN."

Cross Country Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.71%), Wellington Management Group LLP (5.41%), Systematic Financial Management LP (5.33%), Principal Financial Group Inc. (5.29%), Dimensional Fund Advisors LP (5.26%) and Simcoe Capital Management LLC (4.75%). Insiders that own company stock include Colin Patrick Mcdonald, Cynthia Ann Grieco, Daniele Addis, John Anthony Martins, Joseph Trunfio, Kevin Cronin Clark, Stephen Alexis Saville, Susan E Ball, W Larry Cash and William J Burns.
View institutional ownership trends.

Shares of CCRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CCRN stock can currently be purchased for approximately $27.86.

Cross Country Healthcare (NASDAQ:CCRN) has a market capitalization of $1.00 billion and generates $2.81 billion in revenue each year. The business services provider earns $188.46 million in net income (profit) each year or $4.19 on an earnings per share basis.

The company employs 12,980 workers across the globe.

Cross Country Healthcare's mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The official website for the company is www.crosscountryhealthcare.com. The business services provider can be reached via phone at (561) 998-2232, via email at ir@crosscountry.com, or via fax at 302-636-5454.